Gene · 868
Papers1,946
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,946
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small Interfering RNA in Colorectal Cancer Liver Metastasis Therapy. | Technol Cancer Res Treat | 2022 | 35899305 | PubTator, text mining | PubMed |
| Effects of Spore-Displayed p75 Protein from Lacticaseibacillus rhamnosus GG on the Transcriptional Response of HT-29 Cells. | Microorganisms | 2022 | 35888995 | PubTator, text mining | PubMed |
| Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm. | Cancers (Basel) | 2022 | 35884435 | PubTator, text mining | PubMed |
| Activation and Pharmacological Regulation of Inflammasomes. | Biomolecules | 2022 | 35883561 | PubTator, text mining | PubMed |
| Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis. | Front Cell Dev Biol | 2022 | 35874839 | PubTator, text mining | PubMed |
| Transforming growth factor-β signaling governs the differentiation program of extravillous trophoblasts in the developing human placenta. | Proc Natl Acad Sci U S A | 2022 | 35867736 | PubTator, text mining | PubMed |
| Uncovering Signals of Positive Selection in Peruvian Populations from Three Ecological Regions. | Mol Biol Evol | 2022 | 35860855 | PubTator, text mining | PubMed |
| Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib. | JCI Insight | 2022 | 35852869 | PubTator, text mining | PubMed |
| Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer. | Breast Cancer Res | 2022 | 35850772 | PubTator, text mining | PubMed |
| The Abl/Abi signaling links WAVE regulatory complex to Cbl E3 ubiquitin ligase and is essential for breast cancer cell metastasis. | Neoplasia | 2022 | 35839699 | PubTator, text mining | PubMed |
| CD11b suppresses TLR activation of nonclassical monocytes to reduce primary graft dysfunction after lung transplantation. | J Clin Invest | 2022 | 35838047 | PubTator, text mining | PubMed |
| Gallic acid induces T-helper-1-like Treg cells and strengthens immune checkpoint blockade efficacy. | J Immunother Cancer | 2022 | 35817479 | PubTator, text mining | PubMed |
| Emergence of the CD226 Axis in Cancer Immunotherapy. | Front Immunol | 2022 | 35812451 | PubTator, text mining | PubMed |
| Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review. | Nutrients | 2022 | 35807785 | PubTator, text mining | PubMed |
| Posttranslational Regulation of Inflammasomes, Its Potential as Biomarkers and in the Identification of Novel Drugs Targets. | Front Cell Dev Biol | 2022 | 35800898 | PubTator, text mining | PubMed |
| Identification of Biomarkers Associated With CD8+ T Cells in Coronary Artery Disease and Their Pan-Cancer Analysis. | Front Immunol | 2022 | 35799780 | PubTator, text mining | PubMed |
| Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges. | J Zhejiang Univ Sci B | 2022 | 35794685 | PubTator, text mining | PubMed |
| Pemphigus vulgaris in an elderly woman diagnosed with subacute thyroiditis: A case report. | Aging Med (Milton) | 2022 | 35783118 | PubTator, text mining | PubMed |
| A genome-wide association study of bronchodilator response in participants of European and African ancestry from six independent cohorts. | ERJ Open Res | 2022 | 35769418 | PubTator, text mining | PubMed |
| Strong Selectional Forces Fine-Tune CpG Content in Genes Involved in Neurological Disorders as Revealed by Codon Usage Patterns. | Front Neurosci | 2022 | 35757545 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/868/papers?page=19